GSK - Elliott could push for sale cost cutting at BioMarin - analyst
2023-11-07 10:53:35 ET
More on BioMarin Pharmaceutical
- BioMarin: Keeping Bullish View After Q3 Earnings
- BioMarin Pharmaceutical Inc. 2023 Q3 - Results - Earnings Call Presentation
- Biomarin Pharmaceutical, Inc. (BMRN) Q3 2023 Earnings Call Transcript
- Biggest stock movers today: BioMarin, Alteryx, Tripadvisor and more
- BioMarin surges amid report activist Elliott targeting the drugmaker
For further details see:
Elliott could push for sale, cost cutting at BioMarin - analyst